ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $31,000 | -56.3% | 61,157 | -37.0% | 0.00% | – |
Q2 2020 | $71,000 | +36.5% | 97,138 | +83.3% | 0.00% | – |
Q1 2020 | $52,000 | -92.6% | 53,001 | -84.4% | 0.00% | -100.0% |
Q4 2019 | $703,000 | -45.8% | 340,708 | -23.3% | 0.00% | -66.7% |
Q3 2019 | $1,297,000 | -31.2% | 444,263 | +78.3% | 0.00% | -25.0% |
Q2 2019 | $1,886,000 | -29.9% | 249,203 | +22.6% | 0.00% | -20.0% |
Q1 2019 | $2,691,000 | +65.7% | 203,268 | +92.6% | 0.01% | +25.0% |
Q4 2018 | $1,624,000 | +60.8% | 105,523 | +105.3% | 0.00% | +100.0% |
Q3 2018 | $1,010,000 | -11.8% | 51,389 | +28.8% | 0.00% | 0.0% |
Q2 2018 | $1,145,000 | +10.3% | 39,891 | -9.1% | 0.00% | 0.0% |
Q1 2018 | $1,038,000 | +4.8% | 43,891 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $990,000 | -7.0% | 43,891 | -2.4% | 0.00% | 0.0% |
Q3 2017 | $1,064,000 | +5.8% | 44,991 | -11.9% | 0.00% | 0.0% |
Q2 2017 | $1,006,000 | -13.1% | 51,091 | -7.3% | 0.00% | 0.0% |
Q1 2017 | $1,157,000 | +5.7% | 55,104 | -7.7% | 0.00% | 0.0% |
Q4 2016 | $1,095,000 | – | 59,691 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |